This is perhaps due to the biochemical composition of tau in primary tauopathies, differences in molecular structure of the p-tau aggregates between the different tauopathies including between CTE and AD [10, 11], the spatial distribution and severity of tau pathology, as well as other reasons. This evidence concerns the gene MAPT and tauopathy.